Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phosphorus counting table with fixed-dose versus self-adjusted sevelamer in hemodialysis patients
RBR-94dhdyCompleted
- Sponsor
- Faculdade de Medicina de Ribeirão Preto
- Start
- Feb 2015
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Open-label trial of sevelamer carbonate in hyperphosphatemia and chronic kidney disease-mineral and bone disorder (CKD-MBD) (3 arms), sponsored by Faculdade de Medicina de Ribeirão Preto. Started Feb 2015; status: completed.
02
Drugs
sevelamer carbonate
03
Conditions
hyperphosphatemiachronic kidney disease-mineral and bone disorder (CKD-MBD)
Beyond the preview
Go deeper on RBR-94dhdy.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-94dhdy.